SCHEMBL19923699

SCHEMBL19923699

C[Si](C)(C)N1C(=O)N(c2ccccc2)C(c2ccccc2)(c2ccccc2)C1=O

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR1A P08908 3/20 0.35
HTR7 P34969 3/20 0.35
HTR6 P50406 3/20 0.35
ALDH1A1 P00352 1/20 0.35
BACE1 P56817 2/20 0.34
BACE2 Q9Y5Z0 2/20 0.34
ELANE P08246 2/20 0.34
REN P00797 1/20 0.34
APP P05067 1/20 0.34
HSD11B1 P28845 1/20 0.34
TSHR P16473 1/20 0.33
PKM P14618 1/20 0.33
RXFP1 Q9HBX9 1/20 0.32
CACNA1B Q00975 1/20 0.32
APBA1 Q02410 1/20 0.32
MEN1 O00255 1/20 0.32
NPC1 O15118 1/20 0.32
RAB9A P51151 1/20 0.32
KMT2A Q03164 1/20 0.32
GAA P10253 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19923554 0.83 ELANE (0.38) HTR1AHTR7HTR6ALDH1A1BACE1
SCHEMBL19923491 0.83 ALDH1A1 (0.34) HTR1AHTR7HTR6ALDH1A1BACE1
SCHEMBL19923499 0.83 ALDH1A1 (0.37) HTR1AHTR6ALDH1A1BACE1BACE2
SCHEMBL19923603 0.82 ELANE (0.37) HTR1AHTR7HTR6ALDH1A1BACE1
SCHEMBL19923458 0.80 GRM4 (0.44) ALDH1A1ELANECACNA1BAPBA1MEN1
SCHEMBL19923735 0.80 PKM (0.41) HTR1AHTR7HTR6ALDH1A1BACE1
SCHEMBL19923688 0.80 ALDH1A1 (0.37) HTR1AHTR7HTR6ALDH1A1BACE1
SCHEMBL19923633 0.79 ELANE (0.41) BACE1BACE2ELANETSHRMEN1
SCHEMBL19923579 0.77 SMN1; SMN2 (0.38) ALDH1A1BACE1BACE2RENAPP
SCHEMBL19923716 0.76 BACE1 (0.40) HTR1AHTR7HTR6ALDH1A1BACE1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10899718-B2 Polymers functionalized with N-protected hydantoin compounds BRIDGESTONE CORPORATION (JP) 2021-01-26 US claimed
US-20180065935-A1 POLYMERS FUNCTIONALIZED WITH N-PROTECTED HYDANTOIN COMPOUNDS BRIDGESTONE CORPORATION (JP) 2018-03-08 US claimed
US-10899718-B2 Polymers functionalized with N-protected hydantoin compounds BRIDGESTONE CORPORATION (JP) 2021-01-26 US disclosed
US-20180065935-A1 POLYMERS FUNCTIONALIZED WITH N-PROTECTED HYDANTOIN COMPOUNDS BRIDGESTONE CORPORATION (JP) 2018-03-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180065935-A1 POLYMERS FUNCTIONALIZED WITH N-PROTECTED HYDANTOIN COMPOUNDS PARG, HNMT, PARN HTR1A 456/4885HTR7 168/4885HTR6 77/4885
US-10899718-B2 Polymers functionalized with N-protected hydantoin compounds HNMT, PARG, PAM HTR1A 341/4885HTR7 136/4885HTR6 77/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.